473706-10-4

Upstream product

• 5414-19-7 1,1'-oxybis(2-bromo-ethane) 
• 459-22-3 4-fluorophenylacetonitrile 
• 135420-00-7 (4-fluoromethyl-phenyl)-acetonitrile 
• 111-44-4 3-oxa-1,5-dichloropentane 

Downstream Products

• 1338349-02-2 tert-butyl 4-({[4-(4-fluorophenyl)tetrahydro-2H-pyran-4-yl]methyl}carbamoyl)piperidine-1-carboxylate 
• 889939-79-1 C₁₂H₁₆FNO 
• 1338349-10-2 1-benzyl-N-{[4-(4-fluorophenyl)tetrahydro-2H-pyran-4-yl]methyl}piperidine-4-carboxamide hydrochloride 

Relevant academic research and scientific papers

INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO)

The present disclosure provides compounds of Formula (I). The compounds described herein may be useful in treating a disease associated with IDO, for example, cancer or an infectious disease (e.g., viral or bacterial infectious diseases). Also, provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.

NOVEL TRPV3 MODULATORS

Disclosed herein are modulators of TRPV3 of formula (I) wherein G1, X1, X2, X3, X4, X5, G2, Z1, Ra, Rb, u, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.

Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4- fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents

We synthesized and evaluated inhibitory activity against T-type Ca 2+ channels for a series of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl) butyl]piperidine-4-carboxamide derivatives. Structure-activity relationship studies have revealed that dialkyl substituents at the benzylic position play an important role in increasing inhibitory activity. Oral administration of N-[2-ethyl-2-(4-fluorophenyl)butyl]-1-(2-phenylethyl)piperidine-4-carboxamide (20d) lowered blood pressure in spontaneously hypertensive rats without inducing reflex tachycardia, which is often caused by traditional L-type Ca2+ channel blockers.

OXADIAZOLE COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS

This invention relates to novel compounds of formula (I) wherein R1, R2, R3, R4, R5, G1, G2, Y, n, and Ar1 are as defined in the specification, pharmaceutical composit